Home About DPP Contact DPP Protocol DPP OS Protocol Manuals Timeline Slides Publications News archive Program Staff

Study Documents Web Site Registry of Published Manuscripts 01/01/03 The Diabetes Prevention Program Research Group. Costs associated with the primary prevention of type 2 diabetes mellitus in the Diabetes Prevention Program. Diabetes Care. 2003 Jan;26(1)36-47. PMCID: PMC1402339. 12/02/02 The Diabetes Prevention Program Research Group. The Diabetes Prevention Program (DPP): Description of lifestyle intervention. Diabetes Care. 2002 Dec;25(12):2165-71. PMCID: PMC1282458. 11/01/02 Delahanty LM, Meigs JB, Hayden D, Williamson DA, Nathan DM, and the DPP Research Group. Psychological and behavioral correlates of baseline BMI in the Diabetes Prevention Program (DPP). Diabetes Care. 2002 Nov;25(11):1992-8. PMCID: PMC1475806. 04/01/03 The Diabetes Prevention Program Research Group. Effects of withdrawal from metformin on the development of diabetes in the Diabetes Prevention Program. Diabetes Care. 2003 Apr;26(4):977-80. PMCID: PMC1360737. 05/15/03 Molitch M, Fujimoto W, Hamman R, Knowler W for the Diabetes Prevention Program Research Group. The Diabetes Prevention Program and its global implications (Singapore paper). J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S103-7. 11/14/02 The Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension. 2002 Nov;40(5)679-86. PMCID: PMC2516377. 08/01/02 Wylie-Rosette J, Delahanty L. An integral role of the dietitian: Implications of the Diabetes Prevention Program. J Am Diet Assoc. 2002 Aug;102(8):1065-8. PMCID: PMC2562572. 04/01/97 Edelstein SL, Knowler WC, Bain RP, Andres R, Barrett-Connor EL, Dowse GK, Haffner SM, Pettit DJ, Sorkin JD, Muller DC, Collins VR, Hamman RF. Predictors of progression from impaired glucose tolerance to NIDDM: An analysis of six prospective studies. Diabetes. 1997 Apr;46(4):701-10. PMCID: PMC2517225. 04/01/99 The Diabetes Prevention Program Research Group. The Diabetes Prevention Program: Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care. 1999 Apr;22(4):623-34. PMCID: PMC1351026. 11/01/00 The Diabetes Prevention Program Research Group. The Diabetes Prevention Program: Baseline characteristics of the randomized cohort. Diabetes Care. 2000 Nov;23(11):1619-29. PMCID: PMC1360735. 02/07/02 The Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002 Feb 7;346(6);393-403. PMCID: PMC1370926. 04/01/02 The Diabetes Prevention Program Research Group. The Diabetes Prevention Program: Recruitment methods and results. Control Clin Trials. 2002 Apr;23(2):157-71. PMCID: PMC2556984. 04/01/00 Fujimoto WY. Background and recruitment data for the U.S. Diabetes Prevention Program. Diabetes Care. 2000 Apr;23 Suppl 2:B11-3. PMCID: PMC2505054. 10/01/99 The Diabetes Prevention Program Research Group. Response to Adler, Turner, Singer et al. Diabetes Care. 1999 Oct;22(10):1757-8. 06/06/02 Knowler W for the Diabetes Prevention Program Research Group. Response to Bo-abbas, Brousseau, Louria, Benjamin et al. N Engl J Med. 2002 Jun 6;346(23):1829-30. 09/01/03 The Diabetes Prevention Program Research Group. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care. 2003 Sep;26(9):2518-23. PMCID: PMC1360736. 09/01/03 Molitch M. for the Diabetes Research Group. Response to Scheen and Buchaan. Diabetes Care. 2003 Sep;26(9):2702-3. 09/26/04 Mayer-Davis EJ, Sparks KC, Hirst K, Costacou T, Lovejoy JC, Regensteiner JG, Hoskin M, Kriska AM, Bray G and the Diabetes Prevention Program Research Group. Dietary intake in the Diabetes Prevention Program cohort: Baseline and 1-year post-randomization. Ann Epidemiol. 2004 Nov;14(10):763-72. PMCID: PMC2505047. 09/01/04 The Diabetes Prevention Program Research Group. Achieving weight and activity goals among Diabetes Prevention Program lifestyle participants. Obes Res. 2004 Sep;12(9):1426-34. PMCID: PMC2505058. 01/01/05 The Diabetes Prevention Program Research Group. Strategies to identify adults at high risk for type 2 diabetes. Diabetes Care. 2005 Jan;28(1):138-44. PMCID: PMC1314971. 03/01/05 Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE for the Diabetes Prevention Program Research Group. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005 Mar;142(5):323-32. PMCID: PMC2701392 04/01/05 The Diabetes Prevention Program Research Group. Depression symptoms and antidepressant medicine use in Diabetes Prevention Program participants. Diabetes Care. 2005 Apr;28(4):830-7. PMCID: PMC1314970. 04/01/05 The Diabetes Prevention Program Research Group. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program. Diabetes Care. 2005 Apr;28(4):888-94. PMCID: PMC1307521. 04/01/05 The Diabetes Prevention Program Research Group. Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes. 2005 Apr;54(4):1150-6. PMCID: PMC1351025. 04/19/05 Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Fowler S, for the Diabetes Prevention Program Research Group. The effect of metformin and lifestyle intervention on the metabolic syndrome: The Diabetes Prevention Program Randomized Trial. Ann Intern Med. 2005 Apr 19;142(8):611-19. PMCID: PMC2505046. 05/01/05 Diabetes Prevention Program Research Group. Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes. 2005 May;54(5):1566-72. PMCID: PMC1314967. 08/01/05 The Diabetes Prevention Program Research Group. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the Diabetes Prevention Program: Effects of lifestyle intervention and metformin. Diabetes. 2005 Aug;54(8):2404-14. PMCID: PMC1360738. 10/04/05 The Diabetes Prevention Program Research Group. Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the Diabetes Prevention Program. Diabetes Care. 2005 Oct;28(10):2472-9. PMCID: PMC1404506. 02/01/06 Brown JS, Wing R, Barrett-Connor E, Nyberg LM, Kusek JW, Orchard TJ, Ma Y, Vittinghoff E, Kanaya AM for the Diabetes Prevention Program Research Group. Lifestyle intervention is associated with lower prevalence of urinary incontinence: The Diabetes Prevention Program. Diabetes Care. 2006 Feb;29(2):385-90. 12/01/05 Hoskin M, Begay S, Bolin P, Hermes J, Ingraham L, Killean T, Nelson J, Percy C, Scurlock N, Shovestull LE, Tomchee C, the Diabetes Prevention Program and Action for Health in Diabetes (Look AHEAD) research groups. Providing lifestyle interventions in American Indian communities. Obesity Management Journal 2005 Dec;1(6):251-5. 03/28/06 Ratner R for the Diabetes Prevention Program Research Group. An Update on the Diabetes Prevention Program. Endocr Prac. 2006 Jan-Feb;12 Suppl 1:20-4. PMCID: PMC1751934. 04/01/06 Carnethon MR, Prineas RJ, Temprosa M, Zhang Z, Uwaifo G, Molitch ME for the Diabetes Prevention Program Research Group. The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. Diabetes Care. 2006 Apr;29(4):914-9. PMCID: PMC1751934. 05/01/06 Kriska AM, Edelstein SL, Hamman RF, Otto A, Bray GA, Mayer-Davis EJ, Wing RR, Horton ES, Haffner SM, Regensteiner JG. Physical activity in individuals at risk for diabetes: Diabetes Prevention Program. Med Sci Sports Exerc. 2006 May;38(5):826-32. PMCID: PMC1570396. 05/01/06 Delahanty LM, Conroy MB, Nathan DM, and the Diabetes Prevention Program Research Group. Psychological predictors of physical activity in the Diabetes Prevention Program. J Am Diet Assoc. 2006 May;106(5):698-705. PMCID: PMC2495077. 07/20/06 Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PIW, Shuldiner AR, Knowler WC, Nathan DM and Altshuler D for the Diabetes Prevention Program Research Group. TCF7L2 Polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med. 2006 Jul 20;355(3):241-50. PMCID: PMC1762036. 09/01/06 Walker EA, Molitch M, Kramer MK, Kahn S, Ma Y, Edelstein S, Smith K, Johnson MK, Kitabchi A, Crandall J, for the Diabetes Prevention Program Research Group. Adherence to preventive medications: Predictors and outcomes in the Diabetes Prevention Program. Diabetes Care. 2006 Sept;29(9):1997-2002. PMCID: PMC1762037. 09/01/06 Hamman RF, Wing RR, Edelstein SL, Lachin JM, Bray GA, Delahanty L, Hoskin M, Kriska AM, Mayer-Davis EJ, Pi-Sunyer X, Regensteiner J, Venditti B, Wylie-Rosett J, for the Diabetes Prevention Program Research Group. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006 Sep;29(9):2102-7. PMCID: PMC1762038. 11/30/06 The Diabetes Prevention Program Research Group. Relationship of body size and shape to the development of diabetes in the Diabetes Prevention Program. Obesity. 2006 Nov;14(11):2107-17. PMCID: PMC2373982. 10/31/06 The Diabetes Prevention Program Research Group. The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci. 2006 Oct;61(10):1075-81. PMCID: PMC1783677. 02/01/07 Florez JC, Jablonski KA, Kahn SE, Franks PW, Dabelea D, Hamman RF, Knowler WC, Nathan CM and Altshuler D for the Diabetes Prevention Program Research Group. Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program. Diabetes. 2007 Feb;56(2):531-6. PMCID: PMC2267937. 01/26/07 The Diabetes Prevention Program Research Group. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabet Med. 2007 Feb;24(2):137-44. PMCID: PMC2267935. 01/07/07 Florez JC, Jablonski KA, Sun MW, Bayley N, Kahn SE, Shamoon H, Hamman RF, Knowler WC, Nathan DM and Altshuler D for the Diabetes Prevention Program Research Group. Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone. J Clin Endocrinol Metab. 2007;92(4):doi:10.1210/jc.2006-2275. PMCID: PMC2267936. 06/01/07 The Diabetes Prevention Program Research Group. Body size and shape changes and the risk of diabetes in the Diabetes Prevention Program (DPP). Diabetes. 2007 Jun;56:1680-5. PMCID: PMC2528279. 04/01/07 Lachin JM, Christophi CA, Edelstein SL, Ehrmann DA, Hamman RF, Kahn SE, Knowler WC, Nathan DM for the Diabetes Prevention Program Research Group. Factors associated with diabetes onset during metformin versus placebo therapy in the Diabetes Prevention Program. Diabetes. 2007 Apr;56:1153-59. PMCID: PMC2533728. 10/01/07 Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, Lachin JM, Montez MG, Brenneman T, Barrett-Connor E for the Diabetes Prevention Program Research Group. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care. 2007 Oct;30(10):2453-7. PMCID: PMC2373980. 12/01/07 Franks PW, Jablonski KA, Delahanty L, Hanson RL, Kahn SE, Altshuler D, Knowler WC, Florez JC for the Diabetes Prevention Program Research Group. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia. 2007 Dec;50(12):2451-60. PMCID: PMC2453532. 12/04/07 Florez JC, Jablonski KA, McAteer J, Sandhu MS, Wareham NJ, Barroso I, Franks PW, Altshuler D, Knowler WC for the Diabetes Prevention Program. Testing of diabetes-associated WFS1 polymorphisms in the Diabetes Prevention Program. Diabetologia. 2007 Dec 4;51:451-7. PMCID: PMC2483955. 03/01/08 Rubin RR, Ma Y, Marrero DG, Peyrot M, Barrett-Connor EL, Kahn SE, Haffner SM, Price DW, Knowler WC for the Diabetes Prevention Program Research Group. Elevated depression symptoms, antidepressant medicine use and risk of developing diabetes during the Diabetes Prevention Program. Diabetes Care. 2008 Mar;31(3):420-6. PMCID: PMC2373986. 01/11/08 Mather K, Funahashi T, Matsuzawa Y, Edelstein S, Bray G, Kahn S, Crandall J, Marcovina S, Goldstein B, Goldberg R for the DPP Research Group. Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes. 2008 Apr;57:980-6. PMCID: PMC2529455. 05/20/08 Crandall JP, Knowler WC, Kahn SE, Marrero D, Florez JC, Bray GA, Haffner SM, Hoskin M, Nathan DM for the Diabetes Prevention Program Research Group. The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab. 2008 Jul;4(7):382-93. PMCID: PMC2573045. 07/05/08 Perreault L, Ma Y, Dagogo-Jack S, Horton E, Marrero D, Crandall J, Barrett-Connor E for the Diabetes Prevention Program Research Group. Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program. Diabetes Care. 2008 July;31(7):1416-21. PMCID: PMC2453677. 05/01/08 Bray GA, Jablonski KA, Fujimoto WF, Barrett-Connor E, Haffner S, Hanson RL, Hill JO, Hubbard V, Kriska A, Stamm E, Pi-Sunyer FX for the Diabetes Prevention Program Research Group. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr. 2008 May;87(5):1212-8. PMCID: PMC2517222. 08/19/08 Venditti EM, Bray GA, Carrion-Petersen ML, Delahanty LM, Edelstein SM, Hamman RF, Hoskin MA, Knowler WC, Ma Y for the Diabetes Prevention Program Research Group. First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes. Int J Obes. 2008 July 19; PMCID: PMC2574826. 06/10/08 Moore AF, Jablonski KA, McAteer JB, Saxena R, Pollin TI, Hanson RL, Shuldiner AR, Knowler WC, Altshuler D, Florez JC for the Diabetes Prevention Program Research Group. Extension of type 2 diabetes genome-wide association scan results in the Diabetes Prevention Program. Diabetes. 2008 Sept;57:2503-10. 09/16/08 Friedman AN, Marrero D, Ma Y, Ackermann R, Narayan V, Barrett-Connor E, Watson K, Knowler WC, Horton ES for the Diabetes Prevention Program Research Group. Value of urinary albumin creatinine ratio as a predictor of type 2 diabetes in pre-diabetic individuals. Diabetes Care. 2008 Sept;31:2344-8. PMCID: PMC2584193 12/01/08 Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, Fowler S, Kahn SE; The Diabetes Prevention Program Research Group. Prevention of Diabetes in Women with a History of Gestational Diabetes: Effects of Metformin and Lifestyle Interventions. J Clin Endocrinol Metab. 2008 Dec;93(12):4774-9. PMCID: PMC2626441 08/13/07 Hoerger TJ, Hicks KA, Sorenson SW, Herman WH, Ratner RE, Ackermann RT, Zhang P, Englegau MM. The cost-effectiveness of screening for prediabetes among overweight U.S. adults. Diabetes Care. 2007 Nov;30(11):2874-9. 02/01/09 Moore AF, Jablonski KA, Mason CC, McAteer JB, Arakaki RF, Goldstein BJ, Kahn SE, Kitabchi AE, Hanson RL, Knowler WC, Florez JC for The Diabetes Prevention Program Research Group. The associate of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the Diabetes Prevention Program. J Clin Endocrinol Metab. 2009 Feb;94(2):449-455. PMCID: PMC2646511 03/01/09 Ma Y, Temprosa M, Fowler S, Prineas R, Montez M, Brown-Friday J, Carrion-Petersen M, and Whittington T for the Diabetes Prevention Program Research Group. Evaluating the accuracy of an aneroid sphygmomanometer in a clinical trial setting. Am J Hypertens. 2009 Mar;22(3):263-6. PMCID: PMC2699679 04/01/09 Goldberg RB, Temprosa M, Haffner S, Orchard TJ, Ratner RE, Fowler SE, et al. Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: the Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group. Diabetes Care 2009 Apr;32(4):726-732. PMCID: PMC2660486 04/01/09 The Diabetes Prevention Program Research Group. Changes in albumin excretion in the Diabetes Prevention Program. Diabetes Care. 2009 Apr;32(4):720-5. PMCID: PMC2660489 05/01/09 Ackermann RT, Edelstein SL, Venkat Narayan KM, Zhang P, Engelgau MM, Herman WH, et al. Changes in Health State Utilities With Changes in Body Mass in the Diabetes Prevention Program. Obesity (Silver Spring) 2009 Apr 23. 12/01/08 Franks PW, Jablonski KA, Delahanty LM, McAteer JB, Kahn SE, Knowler WC, Florez JC and Diabetes Prevention Program Research Group. Assessing gene-treatment interactions at the FTO and INSIG2 loci on obesity-related traits in the Diabetes Prevention Program. Diabetologia. 2008 Dec;51(12):2214-23. 09/01/09 Perreault L, Kahn SE, Christophi CA, Knowler WC, Hamman RF, Diabetes Prevention Program Research Group. Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program. Diabetes Care 2009 Sep;32(9):1583-1588. 09/01/09 Crandall JP, Polsky S, Howard AA, Perreault L, Bray GA, Barrett-Connor E, et al. Alcohol consumption and diabetes risk in the Diabetes Prevention Program. Am.J.Clin.Nutr. 2009 Sep;90(3):595-601. 11/14/09 Diabetes Prevention Program Research G. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009 Nov 14;374(9702):1677-1686.